Risk/Reward archive
GE Vernova (GEV) posted 26Q2 revenues of $11.1 billion, up 21.9% YOY. Operating income surged 72.8% to $655 million, driven by revenue growth and higher margins at Power and Electrification, which more than offset a modestly wider loss…
Continue reading →26Q2 revenue was $13.3 billion, up 21.1% over 25Q2. Commercial Engine & Services (CES) revenue rose 21.8%, while Defense & Propulsion Technologies (DPT) revenues were up 34.3%. CES segment profit jumped 19.0%, with a 60 bp decline in…
Continue reading →26Q1 Non-GAAP EPS Beats Consensus. Lowering PT to $24 after Sell-Off but Raising Rating to Buy. AT&T reported 26Q1 GAAP EPS of $0.55, compared with $0.61 in the prior year period. Non-GAAP EPS of $0.55 was up from…
Continue reading →The stock market is running hot so far in 2026. The S&P Composite 1500, a broad measure of the stock market, was up 10.9% year-to-date as of Friday, May 29. Among its components, the large cap S&P 500…
Continue reading →HPE reported 26Q1 GAAP EPS of $0.32 vs. 25Q1’s EPS of $0.27 and my estimate of $0.40. Net revenue increased 18.4% to $9.3 billion primarily because of the Juniper Networks acquisition. On a normalized basis, including Juniper’s pre-acquisition…
Continue reading →Spire reported 26Q1 GAAP EPS of $1.54, better than 25Q1’s EPS of $1.34. Non-GAAP, adjusted EPS was $1.77 vs. $1.34. I had projected a GAAP and Adjusted EPS of $1.77. By segment, Gas Utility’s adjusted earnings were $103.9…
Continue reading →26Q1 GAAP diluted loss per share was $1.22 and net financial earnings per basic share (NFEPS), a non-GAAP measure, was $1.17. That compares with 25Q1’s GAAP diluted EPS of $1.31 and net financial earnings per basic share of…
Continue reading →The 22nd annual Wharton Restructuring and Distressed Investing Conference (WRDIC and wrdic.org) was held on February 20 in New York City. This was my first year attending. The focus of this year’s conference was predominantly on the private…
Continue reading →Matthews International Corporation (MATW) reported 26Q1 revenues of $284.8 million, down 29.1%. Nearly all of the decline was due to divestitures, especially the sale of SGK Solutions last May. Sales at its Memorialization business rose 7.2%, due to…
Continue reading →AWK reported 25Q3 EPS of $1.94, up from $1.80 in 24Q3 and exceeding my estimate of $1.91. Operating revenues rose 9.7% to $1.45 billion. Billed water service volumes dropped 1.0% and estimated average prices increased 10.6%. Operating and…
Continue reading →Public Service Enterprise Group (PEG) reported 25Q3 operating revenues of $3.23 billion, up 22.1% from 24Q3, due once again to base rate increases which more than offset modest volume declines. Diluted GAAP EPS was $1.24 vs. $1.03 last…
Continue reading →Pfizer (PFE) reported 25Q3 revenues of $16.7 billion, down 5.9% from 24Q3 and 6.3% below my estimate. All of the decline was due to declines in COMIRNATY and PAXLOVID, the COVID-19 medicines, compared with both prior year levels…
Continue reading →25Q3 sales rose 3.7% to $17.3 billion, exceeding my estimate by 3.9%. The revenue beat was due mostly to higher than anticipated sales of GARDASIL. Although GARDASIL sales were down 24% YOY, they were up 55% sequentially, breaking…
Continue reading →25Q3 net revenue rose 2.8% to $12.2 billion, as an 18.0% rise in the growth portfolio more than offset an 11.8% decline in the legacy portfolio. Dollar sales gains in Eliquis, Opdivo, Reblozyl, Camzyos and Breyanzi were partially…
Continue reading →GEHC reported 25Q3 revenues of $5.14 billion, up 5.7% YOY and 2.9% above my estimate. Revenues rose 20.0% in Pharmaceutical Diagnostics (PDx), 7.0% in Advanced Visual Solutions, 5.4% in Imaging, but fell 6.2% in Patient Care Solutions (PCS). …
Continue reading →BKR reported 25Q3 GAAP diluted EPS of $0.61 vs. 24Q3’s $0.77 and my estimate of $0.66. Net income was lower than expected due to transaction-related costs and a negative swing in the fair value of equity securities (Abu…
Continue reading →AT&T reported 25Q3 GAAP EPS of $1.29, compared with a loss of $0.03 in the prior year period. Non-GAAP EPS of $0.54 was down from $0.60. I had projected GAAP EPS of $0.86 and non-GAAP EPS of $0.65.
Continue reading →25Q3 revenue was $12.2 billion, up 23.8% over 24Q3. Commercial Engine & Services (CES) revenue rose 26.8%, while Defense & Propulsion Technologies (DPT) was up 26.1%. CES segment profit jumped 26.1%, with a 170 bp rise in margin…
Continue reading →GE Vernova (GEV) posted 25Q3 revenues of $10.0 billion, up 11.8% YOY. Operating income swung from a loss of $359 million to a profit of $366 million, primarily due to a $300 million favorable swing at Wind, and…
Continue reading →RGC Resources, Inc. (RGCO) is a holding company whose subsidiaries include Roanoke Gas Company (Roanoke Gas) and RGC Midstream, LLC (Midstream). Originally established in 1883, Roanoke Gas is a regulated gas utility that distributes and sells natural gas…
Continue reading →HPE reported 25Q3 GAAP EPS of $0.21 vs. 24Q3’s income of $0.24. Net revenue increased 18.5% to $9.1 billion (or 17.7% on a constant currency basis). The increase was due to higher average unit prices in the Server…
Continue reading →The Campbell’s Company (CPB) reported 25Q4 diluted GAAP EPS of $0.48, compared with last year’s loss of $0.01 and my estimate of $0.53. The shortfall was due mostly to lower than expected net sales, as sales volumes declined…
Continue reading →Matthews International Corporation (MATW) reported 25Q3 revenues of $349.4 million, down 18.3%. Most of the decline was due to the sale of SGK Solutions, which was completed in May. Sales at its Memorialization business rose 0.5%, due to…
Continue reading →Spire reported 25Q3 GAAP EPS of $0.29, reversing last year’s 24Q2’s loss of $0.28. Non-GAAP, net economic EPS (NEEPS) was $0.01 vs. a loss of $0.14. I had projected a GAAP and NEEPS loss of $0.08. By segment,…
Continue reading →Public Service Enterprise Group (PEG) reported 25Q2 operating revenues of $2.81 billion, up 15.8% from 24Q2, due to base rate increases which more than offset volume declines. Diluted GAAP EPS was $1.17 vs. $0.87 last year. My GAAP…
Continue reading →25Q3 GAAP diluted loss per share was $0.15 and net financial earnings per basic share (NFEPS), a non-GAAP measure, was $0.06. That compares with 24Q3’s GAAP loss per share of $0.12 and net financial loss per share of…
Continue reading →AWK reported 25Q2 EPS of $1.48, up from $1.42 in 24Q2 and matching my estimate of $1.48. Operating revenues rose 11.1% to $1.28 billion. Billed water service volumes dropped 3.8% and estimated average prices increased 14.8%. Military and…
Continue reading →Pfizer (PFE) reported 25Q2 revenues of $14.7 billion, up 10.3% from 24Q2 and 6.1% above my estimate. The sales gains were broad based across the company’s commercial portfolio, with the greatest dollar contributions coming from the Vyndaqel family,…
Continue reading →25Q2 sales decreased 1.9% to $15.8 billion and were 0.8% below my estimate. GARDASIL sales declined by $1.3 billion or 55%, hurt by a lack of pull through in China. (Thus, the company’s suspension of shipments to China…
Continue reading →25Q2 net revenue rose 0.6% to $12.3 billion, as a 17.9% gain in the growth portfolio more than offset a 14.1% decline in the legacy portfolio. Among the individual medicines, sales gains in Eliquis, Breyanzi, Opdivo, Reblozyl and…
Continue reading →GEHC reported 25Q2 revenues of $5.00 billion, up 3.5% YOY and in line with my estimate. Revenues rose 14.1% in Pharmaceutical Diagnostics (PDx), 3.2% in Advanced Visual Solutions, 1.5% in Imaging and 0.8% in Patient Care Solutions (PCS). …
Continue reading →AT&T reported 25Q2 GAAP EPS of $0.62, compared with $0.49 in the prior year period. Non-GAAP EPS of $0.54 was down from $0.60. I had projected GAAP EPS of $0.46 and non-GAAP EPS of $0.52.
Continue reading →BKR reported 25Q2 GAAP diluted EPS of $0.71 vs. 24Q2’s $0.58 and my estimate of $0.58. Net income was higher than expected due mostly to lower SG&A expenses and a $130 million fair value gain from its equity…
Continue reading →GE Vernova (GEV) posted 25Q2 revenues of $9.1 billion, up 21.9% YOY. Yet, operating income fell 47.4% from $527 million to $378 million, primarily due to the nonrecurrence of $306 million related to an arbitration refund received in…
Continue reading →25Q2 revenue was $11.0 billion, up 21% over 25Q1. Commercial Engine & Services (CES) revenue rose 30%, while Defense & Propulsion Technologies (DPT) was up 7%. CES segment profit jumped 33%, with a 50 bp rise in margin…
Continue reading →Earlier this month, I had the opportunity to sit in on a presentation by and meet the management of CEA Industries, which is based in Louisville CO. CEA became a public company in 2011. Back then, it was…
Continue reading →Public Service Enterprise Group (PEG) reported 25Q1 operating revenues of $3.22 billion, up 16.7% from 24Q1, due to base rate increases and higher volumes associated with the cold winter weather. Diluted GAAP EPS was $1.18 vs. $1.06 last…
Continue reading →HPE reported a 25Q2 GAAP diluted loss of $0.82 per share vs. 24Q2’s income of $0.24. The loss was due to a $1.36 billion ($1.03 per share) impairment charge taken against HPE’s Hybrid Cloud business. The charge was…
Continue reading →The Campbell’s Company (CPB) reported 25Q3 diluted GAAP EPS of $0.22, compared with last year’s $0.45 and my estimate of $0.57. The shortfall was due primarily to an impairment charge taken against its Late July chips business and…
Continue reading →AWK reported 25Q1 EPS of $1.05, up from $0.95 in 24Q1 and above my estimate of $0.98. Operating revenues rose 13.0% to $1.14 billion. Billed water service volumes were up 2.5% and estimated average prices increased 9.5%. Military…
Continue reading →Pfizer (PFE) reported 25Q1 revenues of $13.7 billion, down 7.8% from 24Q1 and 6.5% below my estimate. The shortfalls from the prior year and my estimate were due to much lower than anticipated sales of Paxlovid. Sales of…
Continue reading →25Q1 sales decreased 1.6% to $15.5 billion and were 2.0% below my estimate. Excluding currency, sales rose 1%. Sales gains in KEYTRUDA, WINREVAIR and Animal Health offset a 41% drop in GARDASIL sales, as a sharp drop in…
Continue reading →25Q2 GAAP diluted EPS was $2.02 and net financial earnings per basic share (NFEPS), a non-GAAP measure, was $1.78. That compares with 24Q2 GAAP EPS of $1.22 and NFEPS of $1.41. I had projected GAAP EPS of $1.58…
Continue reading →Spire reported 25Q2 GAAP EPS of $3.51, down from $3.58 in 24Q2. Non-GAAP, net economic EPS (NEEPS) was $3.60, up from $3.45. I had projected GAAP and NEEPS of $3.75. Operating revenues of $1.05 billion were down 6.8%…
Continue reading →GEHC reported 25Q1 revenues of $4.78 billion, up 2.7% YOY and in line with my estimate. Revenues rose 5.5% in Pharmaceutical Diagnostics (PDx), 3.8% in Imaging, 1.0% in Advanced Visual Solutions and 0.8% in Patient Care Solutions (PCS). …
Continue reading →AT&T reported 25Q1 GAAP EPS of $0.61, compared with $0.41 in the prior year period. Non-GAAP EPS of $0.51 was up from $0.48. I had projected GAAP EPS of $0.39 and non-GAAP EPS of $0.49.
Continue reading →Organon (OGN) reported 25Q1 GAAP diluted EPS of $0.33, down from $0.78 a year ago. Non-GAAP EPS was $1.02, down from $1.22. I had anticipated GAAP EPS of $0.61 and non-GAAP EPS of $0.92. Revenues of $1.51 billion…
Continue reading →Matthews International Corporation (MATW) reported 25Q2 revenues of $427.6 million, down 9.3%. Sales at its Memorialization business fell 7.4%, due to the normalization of U.S. death rates after COVID. Industrial Technology’s sales plunged 30.4%, as the energy storage…
Continue reading →Spire reported 25Q1 GAAP EPS of $1.34, down from $1.52 in 24Q1. Non-GAAP, net economic EPS (NEEPS) was $1.34, down from $1.47. I had anticipated economic EPS of $1.49. Operating revenues of $669.1 million were down 11.1% YOY…
Continue reading →25Q1 GAAP diluted EPS was $1.31 and net financial earnings per basic share (NFEPS), a non-GAAP measure, was $1.29. That compares with 24Q1 GAAP EPS of $0.91 and NFEPS of $0.74. I had projected GAAP EPS of $1.19…
Continue reading →Public Service Enterprise Group (PEG) reported 24Q4 operating revenues of $2.46 billion, down 5.4% from 23Q4. Diluted GAAP EPS was $0.57 vs. $1.09 last year. 24Q4 operating income fell 35.7%, as the company last year booked mark-to-market gains…
Continue reading →25Q1 net revenue decreased 5.6% to $11.2 billion, as declines in Eliquis and Revlimid were only partially offset by an increase in Opdivo. BMY’s growth portfolio posted a 16.1% YOY revenue increase, the slowest in a year; while…
Continue reading →BKR reported 25Q1 GAAP diluted EPS of $0.40 vs. 24Q1’s $0.45 and my estimate of $0.55. Net income was lower than expected due mostly to a $140 million loss from the change in fair value of certain equity…
Continue reading →GE Vernova (GEV) posted 25Q1 revenues of $8.0 billion, up 21.3% YOY. Operating income swung from a loss of $289 million to income of $43 million. With pension and other income, net of interest costs, pre-tax earnings swung…
Continue reading →25Q1 revenue was $9.9 billion, up 10% over 24Q1. Commercial Engine & Services (CES) revenue rose 14.4%, while Defense & Propulsion Technologies (DPT) was essentially flat. CES segment profit jumped 36%, with a 420 bp rise in margin…
Continue reading →Mistras Group reported 24Q4 EPS of $0.17 vs. 23Q4’s loss of $0.08 and my estimate of $0.14. Revenues of $172.7 million declined 5.1%, due to a 10.1% decline in Mistras’s largest industry served, Oil & Gas, that was…
Continue reading →HPE reported 25Q1 GAAP diluted EPS of $0.44 vs. 24Q1’s $0.29. Non-GAAP EPS was $0.49 vs. $0.48. Net revenue of $7.85 billion was 16.3% higher than last year and exceeded my estimate of $7.54 billion. EPS was above…
Continue reading →Citius Pharmaceuticals (CTXR) posted a 25Q1 loss of $9.8 million or $1.30 per share. I had projected a loss of $7.0 million or $0.93 per share. Operating expenses, including R&D, G&A and (non-cash stock-based compensation, were greater than…
Continue reading →The Campbell’s Company (CPB) reported 25Q2 diluted GAAP EPS of $0.58, compared with last year’s $0.68. Non-GAAP EPS of $0.74 was below last year’s $0.80 and my estimate of $0.79. Net sales were $2.69 billion, up 9.3% from…
Continue reading →AWK reported 24Q4 EPS of $1.23, up from $0.88 in 23Q4 and above my estimate of $1.13. Operating revenues rose 16.4% to $1.20 billion. Water and wastewater revenues increased 13.8%, with billed water service volumes up 4.4% and…
Continue reading →24Q4 revenues were $1.59 billion, up 3% at constant currency but down 0.4% YOY and 2.8% below my estimate. GAAP diluted EPS was $0.42, compared with 23Q4’s $2.13 and my estimate of $0.60. Non-GAAP EPS of $0.90 was…
Continue reading →Pfizer (PFE) reported 24Q4 revenues of $17.8 billion, up 24.7% from 23Q4 and 3.4% above my estimate. Sales of Comirnaty were much stronger than expected, but that was mostly offset by lower than projected sales of Paxlovid. GAAP…
Continue reading →GEHC reported 24Q4 revenues of $5.32 billion, up 2.2% YOY and slightly below my estimate of $5.39 billion. Revenues were flat in the Imaging and Patient Care Solutions (PCS) segments, but rose 4.1% in Advanced Visual Solutions (AVS)…
Continue reading →At its Investor Day held on Dec. 3, AT&T outlined its vision for the next stage of its evolution. It aims to drive growth in its consumer broadband business by expanding its fiber optic footprint, increasing the number…
Continue reading →24Q4 sales rose 6.8% to $15.6 billion. Excluding currency, sales rose 9%. Once again, a high teens percentage gain in KEYTRUDA sales more than offset declining sales in most of the rest of the portfolio. GAAP diluted EPS…
Continue reading →24Q4 net revenue rose 7.5% to $12.3 billion, with gains in Eliquis and the growth portfolio more than offsetting LOE-related declines in Revlimid, Pomalyst, Sprycel and Abraxane. Growth portfolio net revenues rose 9.5% sequentially and 29% YOY. Gross…
Continue reading →On March 11, 2025, Matthews International Corporation (MATW) filed a three million share shelf registration under form S-3 with the U.S. Securities and Exchange Commission. Along with the shelf, it also filed a prospectus under which it would…
Continue reading →BKR reported 24Q4 GAAP diluted EPS of $1.18 vs. 23Q4’s $0.43 and my estimate of $0.66. Its net income was higher than expected due mostly to a large income tax benefit. Operating income was 34% below my estimate,…
Continue reading →GE Vernova (GEV) posted 24Q4 revenues of $10.6 billion, up 5%, with growth in both equipment and services. Operating income more than doubled from $195 million to $593 million, as did net income from $205 million to $484…
Continue reading →24Q4 revenue was $10.8 billion, up 14% over 23Q4. Commercial Engine & Services (CES) revenue jumped 19% and Defense & Propulsion Technologies (DPT) rose 4.5%. CES segment profit surged 54%, with a 640 bp increase in margin to…
Continue reading →I am maintaining my $32 price target. With the stock's recent decline, I have raised my rating from outperform to buy. Three proxy voting services recommend shareholders vote for all three Barington Capital nominees. Even so, I will…
Continue reading →Yesterday, the Bureau of Labor Statistics reported that the Consumer Price Index for All Urban Consumers (CPI-U) increased 0.5% on a seasonally adjusted basis is January, after rising 0.4% in December. Year-over-year, the increase was 3.0%, up from…
Continue reading →The stock of Matthews International Corporation (MATW) has lost more than half of its value since 2017. Over that time, the company has struggled to sustain its profitability due to the earnings deterioration in its SGK Brand Solutions’…
Continue reading →Citius Pharmaceuticals (CTXR) posted a 24Q4 loss of $11.8 million or $1.64 per share. Excluding an estimated $6 million milestone payment, which I had incorrectly expensed rather than capitalized, I had projected a $12.5 million or $1.73 per…
Continue reading →Toll Brothers’ 24Q4 EPS was $4.63, up 12.6% from 23Q4’s $4.11. My estimate was $4.24. Consensus was $4.34. Deliveries of 3,431 units increased 24.5% YOY. The average sales price per unit fell 11.3% to $950,000, mostly on sales…
Continue reading →HPE reported 24Q4 GAAP diluted EPS of $0.99 vs. 23Q4’s $0.49. Non-GAAP EPS was $0.58 vs. $0.52. Net revenue of $8.46 billion rose 15.1% vs. last year and exceeded my estimate of $8.25 billion. GAAP EPS was above…
Continue reading →The Campbell’s Company (CPB) reported 25Q1 diluted GAAP EPS of $0.72, compared with last year’s $0.78. Non-GAAP EPS of $0.89 was below last year’s $0.91, but ahead of my estimate of $0.82. Net sales were $2.77 billion, up…
Continue reading →24Q4 GAAP diluted loss per share was $0.91 and net financial earnings per basic share (NFEPS), a non-GAAP measure, was $0.89. That compares with 23Q4 GAAP EPS of $0.38 and NFEPS of $0.30. I had projected GAAP EPS…
Continue reading →Spire reported a 24Q4 GAAP loss of $0.51 per share, better than 23Q4’s $0.66 loss. Its non-GAAP, net economic loss per share (NEEPS) was $0.54, also improved over 23Q4’s $0.78 loss, but worse than my $0.41 loss estimate. …
Continue reading →Mistras Group reported 24Q3 EPS of $0.20 vs. 23Q3’s loss of $0.34 and my estimate of $0.24. Revenues of $182.7 million were up 1.9%, as a 3.6% decline in Mistras’s largest segment, Oil & Gas, was more than…
Continue reading →24Q3 sales rose 4.3% to $16.7 billion. Excluding currency, sales rose 7%. Once again, a double-digit gain in KEYTRUDA sales more than offset declining sales in the rest of the portfolio. GAAP diluted EPS was $1.24, below 23Q3’s…
Continue reading →Pfizer (PFE) reported 24Q3 revenues of $17.7 billion, up 33.8% from 23Q3, and 13% above my estimate. The key driver of the revenue beat came from Paxlovid, which posted sales of $2.7 billion, beating my estimate of $400…
Continue reading →Public Service Enterprise Group (PEG) reported 24Q3 operating revenues of $2.64 billion, up 7.6% from 23Q3. Diluted GAAP EPS was $1.03 vs. $0.27 last year. 24Q3 operating income rose 16%, but most of the gain vs. the prior…
Continue reading →24Q3 net revenue rose 8.4% to $11.9 billion, with gains in Eliquis, Reblozyl, Breyanzi and Opdivo as well as other medicines from BMY’s growth portfolio more than offsetting an LOE-related decline in Sprycel. Growth portfolio net revenues rose…
Continue reading →24Q3 revenues were $1.58 billion, up 4.1% year-over-year and up 5% at constant currency. GAAP diluted EPS was $1.38, compared with 23Q3’s $0.23, but above my estimate of $0.63. Non-GAAP EPS of $0.87 was even with last year,…
Continue reading →AWK reported 24Q3 EPS of $1.80, up from $1.66 in 23Q3 and above my estimate of $1.67. Operating revenues rose 13.4% to $1.32 billion. Water and wastewater revenues increased 11.3%, with billed water service volumes up 2.8% and…
Continue reading →GEHC reported 24Q3 revenues of $4.86 billion, up 0.9% YOY and matching my estimate of $4.90 billion. Revenues were flat, except Life Support Solutions (within the PCS segment), where sales rose 16.8%, and the PDx segment, up 12.5%. …
Continue reading →AT&T reported a 24Q3 GAAP loss of $0.03 per share, reversing last year’s $0.48 profit and falling short of my $0.56 estimate. The loss was entirely due to a $4.4 billion impairment charge taken against its Business Wireline…
Continue reading →BKR reported 24Q3 GAAP diluted EPS of $0.77 vs. 23Q3’s $0.51 and my estimate of $0.63. Non-GAAP EPS was $0.67, compared with $0.42 last year and my estimate of $0.65. Revenues of $6.9 billion rose 4.0% vs. 23Q3,…
Continue reading →GE Vernova (GEV) reported a 24Q3 GAAP diluted loss per share of $0.35 compared with 23Q3’s pro forma loss of $0.62. This quarter saw a big increase in SG&A from standalone corporate and higher restructuring costs. Excluding those…
Continue reading →GE Aerospace reported 24Q3 revenues of $9.8 billion, up 5.8% vs. the prior year; GAAP EPS from continuing operations was $1.56, compared with 23Q3’s $0.20; and non-GAAP EPS was $1.15 vs $0.92. Results exceeded my estimates of $1.18…
Continue reading →Spire Inc. (NYSE:SR) is a public utility holding company based in St. Louis, MO. The company operates in three segments: Gas Utility, Gas Marketing and Midstream. Its Gas Utility segment accounts for 93% of Spire’s operating revenues and…
Continue reading →Campbell Soup Company (CPB) reported 24Q4 diluted GAAP loss per share of $0.01, compared with last year’s profit of $0.41. Non-GAAP EPS of $0.63, above last year’s $0.50, and matching my estimate of $0.63. Net sales were $2.39…
Continue reading →HPE reported 24Q3 GAAP diluted EPS of $0.38, above 23Q3’s $0.35. Non-GAAP EPS was $0.50 vs. $0.49 last year. Net revenue of $7.71 billion rose 10.1% vs. the previous year. Results exceeded my estimates of $7.60 billion in…
Continue reading →Stocks logged another month of gains in August, but once again September, it has started off with a sharp sell-off.
Continue reading →GE Aerospace reported 24Q2 revenues of $9.1 billion, up 3.9% year-over-year; GAAP EPS from continuing operations was $1.20, compared with 23Q2’s $1.09; and non-GAAP EPS was $1.20 vs $0.74. The mean estimates of analysts were $8.6 billion for…
Continue reading →Toll Brothers’ 24Q3 EPS was $3.60, down 3.5% from 23Q3’s $3.73. My estimate was $3.18. Consensus was $3.31. Deliveries of 2,814 units increased 11.5% YOY. The average sales price per unit fell 8.6% to $968,200. Adjusted gross margin…
Continue reading →Last year at this time, when I last wrote about DHC, the Trust had proposed to merge with another RMR Group affiliate, Office Properties Income Trust (OPI). That merger proposal was scuttled by opposing DHC shareholders.
Continue reading →Citius Pharmaceuticals (CTXR) posted a 24Q3 loss of $10.9 million or $0.06 per share, matching my estimate. R&D expense fell by $1.0 million or 26.6% vs. the prior year, while general & administrative expense increased $1.1 million or…
Continue reading →24Q3 GAAP diluted loss per share was $0.12 and net financial loss per basic share, a non-GAAP measure, was $0.09. That compares with 23Q3 GAAP EPS of $0.02 and net financial earnings per share (NFEPS) of $0.10. I…
Continue reading →